Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

FDA announces new recall for extended-release metformin due to contamination

Numerous recalls for ER metformin occurred in 2020. This is the first of 2021.

Why heart failure patients should receive a COVID-19 vaccine as quickly as possible

New research, published in ESC Heart Failure, details why heart failure patients are a high-risk group and will benefit from vaccination. 

Dr. Makary: ‘Just because you can get the vaccine doesn’t mean you should’

Among the many Americans refusing to get vaccinated against COVID-19 when their turn comes up is a prominent surgeon who’s also a professional medical communicator and a Johns Hopkins public-health professor.

More than 30% of 5K surveyed intend to forego COVID vaccination

It’s not inconvenience or expectations of long waits that are prompting the deliberated refusals.

Thumbnail

In-hospital stroke rates higher after TAVR than MitraClip procedures

Post-discharge stroke rates, however, were similar between the two procedures.

Thumbnail

Non‐vitamin K antagonist oral anticoagulants vs. warfarin for AFib patients: What the latest research tells us

Tracking data from more than 10,000 patients, researchers shared their findings in Diabetes, Obesity and Metabolism.

AI enables faster, smarter inoculations at COVID drive-throughs

Academic experts in disaster response have developed an AI-based simulation model that accurately predicts ebbs and flows in traffic at drive-through vaccination stations.

Returning to Play: The Evolution of Cardiac Guidelines for Athletes with COVID-19

Our understanding of COVID-19 has evolved greatly since its first appearance in the U.S. in early 2020. Though our knowledge remains incomplete, we’ve learned a lot about the pathophysiology of the virus—especially its unique effects on the heart.